Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
The purpose of this study is to determine the feasibility of administering DL-alpha-difluoromethylornithine (DFMO) to patients with relapsed Ewing sarcoma and …
Osteosarcoma RecurrentEwing's Tumor Recurrent
Estimated
~$10 – $6,250
Montefiore Medical CenterNCT06892678
Phase 1
Study of Tegavivint, a Transducin Beta-like Protein 1 (TBL1) Inhibitor, With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
The goal of this clinical trial is to define the maximum tolerated dose (MTD) and/or Recommended phase 2 dose (RP2D) of Tegavivint in combination with Gemcitab…
Osteosarcoma RecurrentOsteosarcoma in ChildrenRelapsed Osteosarcoma+1 more
Estimated
~$10 – $6,250
Emory UniversityNCT07144254